These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

398 related items for PubMed ID: 20025930

  • 1. Age-dependent increase in lysosome-associated membrane protein 1 and early-onset behavioral deficits in APPSL transgenic mouse model of Alzheimer's disease.
    Hashimoto T, Ogino K, Shin RW, Kitamoto T, Kikuchi T, Shimizu N.
    Neurosci Lett; 2010 Jan 22; 469(2):273-7. PubMed ID: 20025930
    [Abstract] [Full Text] [Related]

  • 2. Estrogen treatment improves spatial learning in APP + PS1 mice but does not affect beta amyloid accumulation and plaque formation.
    Heikkinen T, Kalesnykas G, Rissanen A, Tapiola T, Iivonen S, Wang J, Chaudhuri J, Tanila H, Miettinen R, Puoliväli J.
    Exp Neurol; 2004 May 22; 187(1):105-17. PubMed ID: 15081593
    [Abstract] [Full Text] [Related]

  • 3. Amyloid beta and impairment in multiple memory systems in older transgenic APP TgCRND8 mice.
    Hanna A, Horne P, Yager D, Eckman C, Eckman E, Janus C.
    Genes Brain Behav; 2009 Oct 22; 8(7):676-84. PubMed ID: 19531156
    [Abstract] [Full Text] [Related]

  • 4. Decreased acetylcholine release is correlated to memory impairment in the Tg2576 transgenic mouse model of Alzheimer's disease.
    Watanabe T, Yamagata N, Takasaki K, Sano K, Hayakawa K, Katsurabayashi S, Egashira N, Mishima K, Iwasaki K, Fujiwara M.
    Brain Res; 2009 Jan 16; 1249():222-8. PubMed ID: 18996097
    [Abstract] [Full Text] [Related]

  • 5. Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities.
    Savonenko A, Xu GM, Melnikova T, Morton JL, Gonzales V, Wong MP, Price DL, Tang F, Markowska AL, Borchelt DR.
    Neurobiol Dis; 2005 Apr 16; 18(3):602-17. PubMed ID: 15755686
    [Abstract] [Full Text] [Related]

  • 6. Beneficial effects of quetiapine in a transgenic mouse model of Alzheimer's disease.
    He J, Luo H, Yan B, Yu Y, Wang H, Wei Z, Zhang Y, Xu H, Tempier A, Li X, Li XM.
    Neurobiol Aging; 2009 Aug 16; 30(8):1205-16. PubMed ID: 18079026
    [Abstract] [Full Text] [Related]

  • 7. Possible involvement of transthyretin in hippocampal beta-amyloid burden and learning behaviors in a mouse model of Alzheimer's disease (TgCRND8).
    Doggui S, Brouillette J, Chabot JG, Farso M, Quirion R.
    Neurodegener Dis; 2010 Aug 16; 7(1-3):88-95. PubMed ID: 20173334
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A novel transgenic rat model with a full Alzheimer's-like amyloid pathology displays pre-plaque intracellular amyloid-beta-associated cognitive impairment.
    Leon WC, Canneva F, Partridge V, Allard S, Ferretti MT, DeWilde A, Vercauteren F, Atifeh R, Ducatenzeiler A, Klein W, Szyf M, Alhonen L, Cuello AC.
    J Alzheimers Dis; 2010 Aug 16; 20(1):113-26. PubMed ID: 20164597
    [Abstract] [Full Text] [Related]

  • 10. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
    van Groen T, Kiliaan AJ, Kadish I.
    Neurobiol Dis; 2006 Sep 16; 23(3):653-62. PubMed ID: 16829076
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Age-progressing cognitive impairments and neuropathology in transgenic CRND8 mice.
    Hyde LA, Kazdoba TM, Grilli M, Lozza G, Brusa R, Zhang Q, Wong GT, McCool MF, Zhang L, Parker EM, Higgins GA.
    Behav Brain Res; 2005 May 28; 160(2):344-55. PubMed ID: 15863231
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The Arctic Alzheimer mutation facilitates early intraneuronal Abeta aggregation and senile plaque formation in transgenic mice.
    Lord A, Kalimo H, Eckman C, Zhang XQ, Lannfelt L, Nilsson LN.
    Neurobiol Aging; 2006 Jan 28; 27(1):67-77. PubMed ID: 16298242
    [Abstract] [Full Text] [Related]

  • 17. Neuropathological characterization of mutant amyloid precursor protein yeast artificial chromosome transgenic mice.
    Kulnane LS, Lamb BT.
    Neurobiol Dis; 2001 Dec 28; 8(6):982-92. PubMed ID: 11741394
    [Abstract] [Full Text] [Related]

  • 18. Age-related evolution of amyloid burden, iron load, and MR relaxation times in a transgenic mouse model of Alzheimer's disease.
    El Tannir El Tayara N, Delatour B, Le Cudennec C, Guégan M, Volk A, Dhenain M.
    Neurobiol Dis; 2006 Apr 28; 22(1):199-208. PubMed ID: 16337798
    [Abstract] [Full Text] [Related]

  • 19. Cycloxygenase-2 activity promotes cognitive deficits but not increased amyloid burden in a model of Alzheimer's disease in a sex-dimorphic pattern.
    Melnikova T, Savonenko A, Wang Q, Liang X, Hand T, Wu L, Kaufmann WE, Vehmas A, Andreasson KI.
    Neuroscience; 2006 Sep 01; 141(3):1149-62. PubMed ID: 16753269
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.